1. Home
  2. PRME vs DCGO Comparison

PRME vs DCGO Comparison

Compare PRME & DCGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • DCGO
  • Stock Information
  • Founded
  • PRME 2019
  • DCGO 2015
  • Country
  • PRME United States
  • DCGO United States
  • Employees
  • PRME N/A
  • DCGO N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • DCGO Managed Health Care
  • Sector
  • PRME Health Care
  • DCGO Health Care
  • Exchange
  • PRME Nasdaq
  • DCGO Nasdaq
  • Market Cap
  • PRME 424.9M
  • DCGO 433.7M
  • IPO Year
  • PRME 2022
  • DCGO N/A
  • Fundamental
  • Price
  • PRME $2.90
  • DCGO $4.51
  • Analyst Decision
  • PRME Strong Buy
  • DCGO Strong Buy
  • Analyst Count
  • PRME 9
  • DCGO 5
  • Target Price
  • PRME $13.13
  • DCGO $6.10
  • AVG Volume (30 Days)
  • PRME 1.3M
  • DCGO 734.1K
  • Earning Date
  • PRME 11-12-2024
  • DCGO 11-07-2024
  • Dividend Yield
  • PRME N/A
  • DCGO N/A
  • EPS Growth
  • PRME N/A
  • DCGO 300.38
  • EPS
  • PRME N/A
  • DCGO 0.29
  • Revenue
  • PRME $800,000.00
  • DCGO $694,968,328.00
  • Revenue This Year
  • PRME N/A
  • DCGO $2.08
  • Revenue Next Year
  • PRME $426.55
  • DCGO N/A
  • P/E Ratio
  • PRME N/A
  • DCGO $15.81
  • Revenue Growth
  • PRME N/A
  • DCGO 30.19
  • 52 Week Low
  • PRME $2.56
  • DCGO $2.75
  • 52 Week High
  • PRME $9.80
  • DCGO $5.70
  • Technical
  • Relative Strength Index (RSI)
  • PRME 41.76
  • DCGO 63.59
  • Support Level
  • PRME $2.56
  • DCGO $4.08
  • Resistance Level
  • PRME $3.04
  • DCGO $4.34
  • Average True Range (ATR)
  • PRME 0.25
  • DCGO 0.25
  • MACD
  • PRME -0.01
  • DCGO -0.00
  • Stochastic Oscillator
  • PRME 36.17
  • DCGO 78.57

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About DCGO DocGo Inc.

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company has three reportable segments: Mobile Health Services, Transportation Services, and Corporate. Mobile Health Services is the key revenue-generating segment for the company.

Share on Social Networks: